CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Prediction MarketWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2979 rapid salivary test Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Can the Prediction Market Improve Predictions of COVID-19?

The goal of this study is to better understand how people predict the future risks of the novel Coronavirus (COVID-19). Specifically, the investigators will ask the following research questions: - How well do participants predict the future risks of COVID-19? - Can the predictions be improved by using a prediction market mechanism? - Does the prediction market reduce people's fear of COVID-19?

NCT04410692 Health Knowledge, Attitudes, Practice Other: Prediction Market

Primary Outcomes

Description: Participants are asked 16 questions of the following format: "What do you think will be the total cumulative number of cases in Singapore on 8th of June, at 12pm?" Each question has 5 answer options. Each answer option is a range of possible outcomes. The primary outcome measure is participants' perceived likelihood of each answer option. The 16 questions come from the following variations: 4 countries (Mexico, Singapore, Turkey, USA) x 2 outcome measures (cases, deaths) x 2 time periods (8th of June, 6th of July).

Measure: Predictions of COVID-19 Cases and Deaths

Time: 24 hours

Secondary Outcomes

Description: Fear is measured by participants' responses to subjective attitude questions in the post-experiment survey. The questions are on a 5-point Likert scale.

Measure: Fear

Time: 24 hours (participants are required to submit post-experiment survey within 24 hours of completion of the main experiment)


No related HPO nodes (Using clinical trials)